Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 10:13:17 UTC
Update Date2021-09-26 23:04:51 UTC
HMDB IDHMDB0252339
Secondary Accession NumbersNone
Metabolite Identification
Common NameFlumezapine
Description12-fluoro-5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),3(7),5,8,11,13-hexaene belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms). Based on a literature review very few articles have been published on 12-fluoro-5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(10),3(7),5,8,11,13-hexaene. This compound has been identified in human blood as reported by (PMID: 31557052 ). Flumezapine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Flumezapine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
7-Fluoro-2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno(2,3b)(1,5)benzodiazepineMeSH
Chemical FormulaC17H19FN4S
Average Molecular Weight330.43
Monoisotopic Molecular Weight330.131445965
IUPAC Name12-fluoro-5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene
Traditional Name12-fluoro-5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene
CAS Registry NumberNot Available
SMILES
CN1CCN(CC1)C1=NC2=C(NC3=C1C=C(C)S3)C=CC(F)=C2
InChI Identifier
InChI=1S/C17H19FN4S/c1-11-9-13-16(22-7-5-21(2)6-8-22)19-15-10-12(18)3-4-14(15)20-17(13)23-11/h3-4,9-10,20H,5-8H2,1-2H3
InChI KeyJBHUBOISLBWHAR-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms).
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzodiazepines
Sub ClassNot Available
Direct ParentBenzodiazepines
Alternative Parents
Substituents
  • Benzodiazepine
  • Thieno-para-diazepine
  • 2,3,5-trisubstituted thiophene
  • Para-diazepine
  • N-methylpiperazine
  • N-alkylpiperazine
  • N-arylated-2-aminothiophene
  • Piperazine
  • Aryl fluoride
  • Aryl halide
  • 2-aminothiophene
  • Imidolactam
  • 1,4-diazinane
  • Benzenoid
  • Thiophene
  • Heteroaromatic compound
  • Tertiary aliphatic amine
  • Tertiary amine
  • Amidine
  • Azacycle
  • Organic 1,3-dipolar compound
  • Carboxylic acid amidine
  • Propargyl-type 1,3-dipolar organic compound
  • Amine
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Organohalogen compound
  • Organofluoride
  • Organonitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.41ALOGPS
logP3.53ChemAxon
logS-3.8ALOGPS
pKa (Strongest Acidic)13.29ChemAxon
pKa (Strongest Basic)7.22ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area30.87 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity94.09 m³·mol⁻¹ChemAxon
Polarizability35.5 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+179.40830932474
DeepCCS[M-H]-177.0530932474
DeepCCS[M-2H]-210.17630932474
DeepCCS[M+Na]+185.50130932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
FlumezapineCN1CCN(CC1)C1=NC2=C(NC3=C1C=C(C)S3)C=CC(F)=C24160.5Standard polar33892256
FlumezapineCN1CCN(CC1)C1=NC2=C(NC3=C1C=C(C)S3)C=CC(F)=C22612.8Standard non polar33892256
FlumezapineCN1CCN(CC1)C1=NC2=C(NC3=C1C=C(C)S3)C=CC(F)=C22777.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Flumezapine,1TMS,isomer #1CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=C(F)C=C1N=C2N1CCN(C)CC12777.6Semi standard non polar33892256
Flumezapine,1TMS,isomer #1CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=C(F)C=C1N=C2N1CCN(C)CC12724.8Standard non polar33892256
Flumezapine,1TMS,isomer #1CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=C(F)C=C1N=C2N1CCN(C)CC13839.5Standard polar33892256
Flumezapine,1TBDMS,isomer #1CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=C(F)C=C1N=C2N1CCN(C)CC12932.2Semi standard non polar33892256
Flumezapine,1TBDMS,isomer #1CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=C(F)C=C1N=C2N1CCN(C)CC12925.4Standard non polar33892256
Flumezapine,1TBDMS,isomer #1CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=C(F)C=C1N=C2N1CCN(C)CC13907.5Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Flumezapine GC-MS (Non-derivatized) - 70eV, Positivesplash10-05r4-9154000000-6bd7e1b72471a2b7c7612021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Flumezapine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Flumezapine 10V, Positive-QTOFsplash10-001i-0009000000-710819905ce124131bc02021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Flumezapine 20V, Positive-QTOFsplash10-001i-0019000000-90ab6af48f621c9f24722021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Flumezapine 40V, Positive-QTOFsplash10-00di-0191000000-b1a0705c694ad28bbc1f2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Flumezapine 10V, Negative-QTOFsplash10-004i-0009000000-68e214b2e39a05cc93342021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Flumezapine 20V, Negative-QTOFsplash10-004i-0009000000-6108a733530732c5da4e2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Flumezapine 40V, Negative-QTOFsplash10-0a4i-1292000000-e1f8b2e3df60b19b28642021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID10296395
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound135413528
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]